MedPath

Various treatment modalities like oils, tablets and mouthwashes would be given for the treatment of oral submucous fibrosis.

Phase 4
Conditions
Health Condition 1: null- Oral submucous fibrosis
Registration Number
CTRI/2018/08/015166
Lead Sponsor
Maulana Azad institute of dental sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

A sufficient number of sample of patients suffering from oral submucous fibrosis would be taken. They would be subjected to different systemic and topical antioxidants . The improvement in mouth opening, tongue protrusion, VAS scale and cheek flexibility would be assessed.

Exclusion Criteria

1.Pregnant and lactating mothers

2. Patients less than 18 years

3. Patients having intolerance to any of the drugs to be used in the study

4.Those not willing to participate.

5.Patients already undergoing some treatment for existing OSMF

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Mouth opening <br/ ><br>2. VAS Scale <br/ ><br>3. Burning sensation <br/ ><br>4. Cheek flexibility <br/ ><br>Timepoint: Patients would be assessed after 15 days initially followed by 1 month. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
to assess the side effects of the drugs given , malignant potential of the diseaseTimepoint: the drugs would be given for a period of 3 months.
© Copyright 2025. All Rights Reserved by MedPath